Farther Finance Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

Farther Finance Advisors’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-31	Closed	-$1.46K	–	5074
2025 Q2	$1.46K	Sell	31 -8	-21%	-$356	﹤0.01%	3802
2025 Q1	$1.63K	Buy	39 +17	+77%	+$783	﹤0.01%	3460
2024 Q4	$795	Buy	22 +19	+633%	+$664	﹤0.01%	3320
2024 Q3	$96	Buy	+3	New	+$112	﹤0.01%	3785

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farther Finance Advisors's SWTX Position: Q3 2025 in Review

Farther Finance Advisors sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 31 shares — an estimated $1.46K sold.

Farther Finance Advisors first reported a position in SWTX in Q3 2024 and held it in 4 quarters. The position peaked at $1.63K in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Farther Finance Advisors reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Farther Finance Advisors sold 31 SpringWorks Therapeutics shares in Q3 2025, an estimated $1.46K.
Farther Finance Advisors first reported a position in SpringWorks Therapeutics in Q3 2024 and held it in 4 quarters.
Farther Finance Advisors's SpringWorks Therapeutics position peaked at $1.63K in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Farther Finance Advisors's 13F filing for Q3 2025, filed 14 Oct 2025.